Standout Papers

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death 2005 2026 2012 2019 557
  1. Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death (2005)
    Edward Abraham, Pierre‐François Laterre et al. New England Journal of Medicine

Immediate Impact

6 from Science/Nature 55 standout
Sub-graph 1 of 20

Citing Papers

Refining the impact of genetic evidence on clinical success
2024 StandoutNature
A smart mask for exhaled breath condensate harvesting and analysis
2024 StandoutScience
2 intermediate papers

Works of Benjamin Trzaskoma being referenced

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
2018
A randomized multicenter study evaluating Xolair persistence of response after long-term therapy
2016

Author Peers

Author Last Decade Papers Cites
Benjamin Trzaskoma 800 780 323 707 46 2.3k
Ramona L. Doyle 562 2592 278 743 58 4.7k
Jonathan Janes 278 293 503 1398 50 3.5k
Alberto Pesci 1054 2408 72 510 83 3.1k
Vincent Esnault 438 1595 154 233 112 3.6k
D. Adu 515 1729 172 252 58 2.8k
J.P. Daurès 411 330 384 278 72 2.2k
Rodrigo Cartin‐Ceba 389 2103 60 1198 115 4.0k
Julie Lin 429 567 33 446 65 4.2k
Paula J. Santrach 168 204 170 970 81 3.4k
P. Duhaut 530 1492 92 724 109 4.1k

All Works

Loading papers...

Rankless by CCL
2026